D. Boral Capital Downgrades Plus Therapeutics to Hold

Benzinga Newsdesk www.benzinga.com Negative 84.6%

Neg 84.6% Neu 0% Pos 0%

D. Boral Capital analyst Jason Kolbert downgrades Plus Therapeutics (NASDAQ:PSTV) from Buy to Hold.

Comments

No comments yet. Be the first!